Sonic Healthcare Limited (SAB.F)
- Previous Close
16.10 - Open
16.25 - Bid 16.10 x --
- Ask 16.90 x --
- Day's Range
16.25 - 16.50 - 52 Week Range
15.50 - 22.24 - Volume
61 - Avg. Volume
203 - Market Cap (intraday)
7.926B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
25.38 - EPS (TTM)
0.65 - Earnings Date --
- Forward Dividend & Yield 0.63 (3.84%)
- Ex-Dividend Date Mar 1, 2024
- 1y Target Est
--
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
www.sonichealthcare.com41,000
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: SAB.F
Performance Overview: SAB.F
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SAB.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SAB.F
Valuation Measures
Market Cap
7.79B
Enterprise Value
9.83B
Trailing P/E
25.50
Forward P/E
18.02
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.54
Price/Book (mrq)
1.70
Enterprise Value/Revenue
1.17
Enterprise Value/EBITDA
6.36
Financial Highlights
Profitability and Income Statement
Profit Margin
6.02%
Return on Assets (ttm)
3.83%
Return on Equity (ttm)
6.90%
Revenue (ttm)
8.39B
Net Income Avi to Common (ttm)
504.94M
Diluted EPS (ttm)
0.65
Balance Sheet and Cash Flow
Total Cash (mrq)
619.61M
Total Debt/Equity (mrq)
50.49%
Levered Free Cash Flow (ttm)
356.22M
Company Insights: SAB.F
SAB.F does not have Company Insights